Old Web
English
Sign In
Acemap
>
authorDetail
>
Steve Sugarman
Steve Sugarman
University of Alabama at Birmingham
Medicine
Gastroenterology
Doxorubicin
Premedication
Phases of clinical research
4
Papers
163
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Radiation Injury, Burns and Illness: A Review of Best Practices. Your approach should include identifying sources, determining exposure and managing resources.
2016
EMS world
Randy D. Kearns
Steve Sugarman
Charles B. Cairns
James H. Holmes Th
Bruce A. Cairns
Preston B. Rich
Show All
Source
Cite
Save
Citations (0)
Phase I Trial of the Anti–Lewis Y Drug Immunoconjugate BR96-Doxorubicin in Patients With Lewis Y–Expressing Epithelial Tumors
2000
Journal of Clinical Oncology
Mansoor N. Saleh
Steve Sugarman
James A.H. Murray
Joy B. Ostroff
Diane Healey
Dennie Jones
Carol R. Daniel
Donna LeBherz
Hannah Brewer
Nicole Onetto
Albert F. LoBuglio
Show All
Source
Cite
Save
Citations (141)
Phase I T rial o f t he A nti-Lewis Y D rug I mmunoconjugate BR96-Doxorubicin i n P atients W ith L ewis Y -Expressing Epithelial T umors
2000
Mansoor N. Saleh
Steve Sugarman
James L. Murray
Joy B. Ostroff
Diane Healey
Dennie Jones
Carol R. Daniel
Donna LeBherz
Hannah Brewer
Nicole Onetto
Albert F. LoBuglio
Show All
Source
Cite
Save
Citations (0)
Pilot phase II trial of 13-cis-retinoic acid and interferon-α combination therapy for advanced pancreatic adenocarcinoma
1995
American Journal of Clinical Oncology
Dennis F. Moore
Richard Pazdur
Steve Sugarman
Dennie V. Jones
Scott M. Lippman
Beth Bready
James L. Abbruzzese
Show All
Source
Cite
Save
Citations (22)
1